The Omicron Variant: Where Are We Now, and What Is the Future for Testing?
Subscribe to OnAir with Akin Gump via iTunes, SoundCloud, YouTube, Spotify and Google Podcasts.
In this episode of OnAir: Health Care, Akin Gump health care senior policy advisor Matthew Hittle and consultant Dr. Mario Ramirez welcome Dr. Michael Mina, chief science officer for eMed, a digital point-of-care platform.
Among the topics covered:
- The Omicron variant and prospects for 2022.
- The future of COVID testing.
- Biden-Harris administration plans regarding testing.
- Rapid tests and reporting.
To learn more, search for “health care” via the menu at top right.
Attachments
Speakers
© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.